钠/碘同向转运体

柳卫; 张满达; 王铁生

钠/碘同向转运体

柳卫 , 张满达 , 王铁生

文章导航 > 国际放射医学核医学杂志 > 2001, 25 > 2: (49-52)

引用本文:

Citation:

钠/碘同向转运体

214063 江苏无锡, 核医学国家重点实验室

作者简介: 柳卫(1971-),男,江苏南京人,南京医科大学第一附属医院核医学科讲师,复旦大学医学院硕士研究生,现在核医学国家重点实验室主要从事甲状腺疾病研究。;

中图分类号: R581.023;R817.8

The sodium/iodide symporter

LIU Wei,

State key laboratory of nuclear medicine, Jiangsu Wuxi 214063, China
CLC number: R581.023;R817.8

摘要: 钠/碘同向转运体是甲状腺滤泡细胞基底细胞膜上的糖蛋白,介导甲状腺对碘的主动运输。本文综述钠/碘同向转运体在基因、蛋白质二级结构、电生理学特征、调控及组织分布等方面的进展,及其对甲状腺疾病和放射性碘治疗的意义。
- 钠/碘同向转运体 /
- 放射性碘治疗
Abstract: The sodium/iodide symporter (NIS), an integral plasma membrane glycoprotein of the basolateral membrane of the thyroid gland follicular cells, mediates the active transport of iodide into thyroid cells. In this review, the main accomplishments of the study of NIS at molecular level were concisely described, including the NIS gene, the secondary structure and electrophysiological character of NIS protein, and their regulation and tissue distribution. The impacts of NIS on thyroid disease and radioactive iodide therapy were also evaluated.
- sodium/iodide symporter /
- radioactive iodide therapy
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Dai G,Levy O,Carrasco N.Cloning and characterization of the thyroid iodide transporter[J].Nature,1996,379:458-460.
[2]	Smanik PA,Liu Q,Furminger TL,et al.Cloning of the human sodium iodide symporter[J].Biochem Biophys Res Commun,1996,226:339-345.
[3]	Levy O,Vieja A,Ginter CS,et al.N-linked glycosylation of the thyroid Na⁺/I^- symporter (NIS)[J].J Biol Chem,1998,273:22657-22663.
[4]	Smanik PA,Ryu KY,Theil KS,et al.Expression,exon-intron,organization,and mapping of the human sodium iodide symporter[J].Endocrinology,1997,138:3555-3558.
[5]	Eskandari S,Loo DDF,Dai G,et al.Thyroid Na⁺/I^- symporter mechanism stoicchiometry and specificity[J].J Biol Chem,1997,272:27230-27238.
[6]	Yoshida A,Sasaki N,Mori A,et al.Different electro physiological character of I^-,ClO₄^-,and SCN^- in the transport by Na⁺/I^- symporter[J].Biochem Biophys Res Commun,1997,231:731-734.
[7]	Caillou B,Troalen F,Baudin E,et al.Na⁺/I^- symporter distribution in human thyroid tissues:an immunohistochemical study[J].J Clin Endocrinol Metab,1998,83:4102-4106.
[8]	DeleuS,Allory Y,Radulescu A,et al.Characterization of autonomous thyroid adenoma:metabolism gene expression,and pathology[J].Thyroid,2000,10:131-140.
[9]	Arturi F,Russo D,Schlumberger M,et al.Iodide sympoter gene expression in human thyroid tumors[J].J Clin Endocrinol Metab,1998,83:2493-2496.
[10]	Varyre L,Sabourin JC,Caillou B,et al.Immunohistochemical analysis of Na⁺/I^- symporter distribution in human extra-thyroid tissues[J].Eur J Endocrinol,1999,141:382-386.
[11]	Ajjan RA,Kamaruddin NA,Crisp M,et al.Regulation and tissue distribution of the human sodium iodide symporter gene[J].Clin Endocrinol Oxf,1998,49:517-523.
[12]	Spitzweg C,Joba W,Eisenmenger W,et al.Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acid from salivary gland,mammary gland,and gastric mucosa[J].J Clin Endocrinol Metab,1998,83:1746-1751.
[13]	Kogai T,Endo T,Saito T,et al.Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells[J].Endocrinology,1997,138:2227-2232.
[14]	Saito T,Endo T,Kawaguchi A,et al.Increased expression of the sodium/iodide symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue[J].J Clin Endocrinol Metab,1997,82:3331-3336.
[15]	Trapasso F,Iuliano R,Chiefari E,et al.Iodide symporter gene expression in normal and transformed rat thyroid cells[J].Eur J Endocrinol,1999,140:447-451.
[16]	Pekary AE,Hershman JM.Tumor necrosis factor,ceramide,transforming growth factor-betal,and aging reduce Na⁺/I^- symporter messenger ribonucleic acid levels in FRTL-5 cells[J].Endocrinology,1998,139:703-712.
[17]	Suzuki K,Mori A,Saito J,et al.Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene[J].Endocrinology,1999,140:5422-5430.
[18]	Ajjan RA,Watson PF,Findlay C,et al.The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity[J].J Endocrinol,1998,158:351-358.
[19]	Eng PH,Cardona GR,Fang SL,et al.Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein[J].Endocrinology,1999,140:3404-3410.
[20]	Uyttersprot N,Pelgrims N,Carrasco N,et al.Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na⁺/I^- symporter mRN As in dog thyroid[J].Mol Cell Endocrinol,1997,131:195-203.
[21]	Endo T,Kaneshige M,Nakazato M,et al.Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na⁺/I^- symporter gene[J].Mol Endocrinol,1997,11:1747-1755.
[22]	Ohmori M,Endo T,Harri N,et al.A novel thyroid transcription factor is essential for thyrotropin-induced up-regulation of Na⁺/I^- symporter gene expression[J].Mol Endocrinol,1998,12:727-736.
[23]	Ohno M,Zannini M,Levy O,et al.The paired-domain transcription factor pax 8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-speciflc and cyclic-AMP-dependent transcription[J].Mol Cell Biol,1999,19:2051-2060.
[24]	Benvenga S,Bartolone L,Trimarchi F.Thyroid iodide transporter;local sequence homologies with thyroid autoantigens[J].J Endocrinol Invest,1997,20:508-512.
[25]	Mori JC,Bergert ER,Bryant WP.Binding of immunoglobulin G from patients with autoimmune thyroid disease to rat sodium:iodide symporter peptides:evidence for the iodide transporter as a autoantigen[J].Thyroid,1997,7:527-534.
[26]	Ajjan RA,Findlay C,Metcalfe RA,et al.The modulation of the human sodium iodide symporter activity by Graves' disease sera[J].J Clin Endocrinol Metab,1998,83:1217-1221.
[27]	Matsuda A,Kosugi S.A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transporter defect[J].J Clin Endocrinol Metab,1997,82:3966-3971.
[28]	Wang W,Macapinlac H,Larson SM,et al.[¹⁸F]-2-fluoro-deoxy-d-dlucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic ¹³¹I whole body scans and elevated serum thyroglobulin levels[J].J Clin Endocrinol Metab,1999,84:2291-2302.
[29]	Schmutzler C,Winzer R,Meissner WJ,et al.Reti-noic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in non transformed FRTL-5 rat thyroid cells[J].Biochem Biophys Res Commun,1998,246:562-568.
[30]	Schmutzler C,Winzer R,Weigl JM,et al.Retinoic acid-a potential bifunctional therapeutic tool for treating thyroid carcinomas[J].Exp Clin Endocrinol Diabetes,1998,106(Suppl 1):s3.
[31]	Grunwald F,Menzel C,Bender H,et al.Redifferentiation therapy-induced radioiodine uptake in thyroid cancer[J].J Nucl Med,1998,39:1903-1906.
[32]	Mandelell RB,Mendlell LZ,Link CJ Jr.Radioisotope concentrator gene therapy using the sodium/iodide symporter gene[J].Cancer Res,1999,59:661-668.
[33]	Spitzweg C,Zhang S,Bergert ER,et al.Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines[J].Cancer Res,1999,59:2136-2141

[1]	陈立波 . 钠/碘同向转运体与放射性碘治疗. 国际放射医学核医学杂志, 2001, 25(6): 258-261.
[2]	张一帆 , 李彪 . 钠/碘同向转运体在甲状腺癌¹³¹I治疗中的应用. 国际放射医学核医学杂志, 2004, 28(6): 249-252.
[3]	李倩 . 钠/碘转运体的临床实用价值. 国际放射医学核医学杂志, 2003, 27(2): 56-58,65.
[4]	黄蕤 . NIS基因转染肿瘤细胞介导¹³¹I治疗. 国际放射医学核医学杂志, 2001, 25(5): 204-209.
[5]	张静 , 贾茜 , 赵傲梅 , 杨爱民 . 分化型甲状腺癌放射性碘治疗敏感性及其影响因素的研究进展. 国际放射医学核医学杂志, 2022, 46(4): 245-253. doi: 10.3760/cma.j.cn121381-202103030-00168
[6]	罗全勇 . 基因转染诱导核素靶向治疗的实验研究. 国际放射医学核医学杂志, 2001, 25(2): 60-62.
[7]	葛素娟 . 甲状腺癌术后¹³¹I治疗. 国际放射医学核医学杂志, 2002, 26(4): 163-164,168.
[8]	郭睿 , 李彪 . 钠碘同向转运体基因介导放射性碘治疗肿瘤的研究进展. 国际放射医学核医学杂志, 2010, 34(3): 147-151. doi: 10.3760/cma.j.issn.1673-4114.2010.03.005
[9]	欧阳萌 . ¹³¹I治疗儿童及青少年Graves病. 国际放射医学核医学杂志, 2004, 28(2): 70-73.
[10]	张俊 , 刘增礼 . 钠碘转运体基因介导的肿瘤放射性核素治疗研究. 国际放射医学核医学杂志, 2008, 32(1): 8-11.